Genetics meets metabolomics

Scientists at Helmholtz Zentrum Munich and LMU Munich, in cooperation with Wellcome Trust Sanger Institute and King's College London (KCL), have identified several associations between genetic variants and specific metabolic changes. The study, published today in Nature, provides new functional insights regarding associations between risk factors and the development of complex common diseases.

In the study appearing today in the journal Nature, the researchers identified 37 previously unknown loci, elucidated their effect on human metabolism and found clear associations to complex such as type 2 diabetes mellitus. Professor Karsten Suhre and Dr. Christian Gieger of Helmholtz Zentrum München, together with colleagues from the Wellcome Trust Sanger Institute in the UK and King's College London under the leadership of Nicole Soranzo, conducted this research to gain in-depth insight into the etiology of disease. In the study, the scientists present the most comprehensive evaluation of genetic variance in so far, combining genome-wide association studies (GWAS) with metabolomics. Over 250 metabolites were analyzed from 60 disease-relevant metabolic pathways.

"The advantage of our study design," Suhre and Gieger said, "is that we studied genetic variance in its biological context – and thus identified previously unknown risk loci." By combining genetics and metabolomics, a method which already yielded promising results in two previous studies, the scientists were able to evaluate the biological effect of the identified genetic risk loci. In stand-alone GWAS this is not possible.

Every individual is unique – a closer look at the individual's metabolites could enable a better evaluation of the risks for developing complex common diseases in the future. "We have made considerable advances in understanding complex diseases such as ," the two scientists said. "The findings of the study will lead to new approaches for pharmaceutical research."

More information: Human metabolic individuality in biomedical and pharmaceutical research, Suhre K., et. al. Nature online, 1. September 2011

Provided by Ludwig-Maximilians-Universitat Munchen

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Metabolomics as a basis for gender-specific drugs

Aug 11, 2011

Analyses of the metabolic profile of blood serum have revealed significant differences in metabolites between men and women. In a study to be published on August 11 in the open-access journal PLoS Genetics, scientists at the ...

New biochemical discoveries into developing disease

Aug 31, 2011

Researchers have undertaken the most comprehensive investigation of genetic variance in human metabolism and discovered new insights into a range of common diseases. Their work has revealed 37 new variants that are associated ...

Blood counts are clues to human disease

Oct 11, 2009

(PhysOrg.com) -- A new genome-wide association study published today in Nature Genetics begins to uncover the basis of genetic variations in eight blood measurements and the impact those variants can have o ...

Recommended for you

Gene therapy protects mice from heart condition

Aug 20, 2014

A new gene therapy developed by researchers at the University of Missouri School of Medicine has been shown to protect mice from a life-threatening heart condition caused by muscular dystrophy.

Study finds crucial step in DNA repair

Aug 18, 2014

Scientists at Washington State University have identified a crucial step in DNA repair that could lead to targeted gene therapy for hereditary diseases such as "children of the moon" and a common form of ...

User comments